2Morganroth J.Risk factor for the development of proarrythmic events[J].Am J Cardiol,1987,321:406-412.
3The Cardiac Arrhythmia Supperssion Trial (CAST) Investigators.Preliminary report:effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction [ J ].N Engl J Med,1998,321 (6):406-412.
5Nishizawa,S,Shiraishi,J,Torii,S,et al.Intermediate fixed coronary artery stenosis at the site of ergonovine-provoked spasm as a predictor of long-term major adverse cardiac events of patients with coronary spastic angina.Circ J,2009,73(4):699.
6Terao S, Yihnaz G, Stokes KY, et al. B lood cell derived RANTES mediates cerebral microvascular dysfunction,inflammation and tissue injury after fo- cal ischemia reperfusion[J]. Stoke,2010,39(2): 2 560 -2 570.
7Aldhilan between coronary A,Syed GM, transient i Suleiman I, schemic dil artery disease in Saudi et al. Correl atation (TID) male patient ion and [J].J Saudi Heart hssoc,2014,26(1):1-5.
8Vousefzadeh G,Mahdavi JF,Shokoohi M,et al. Modula- tion of coronary artery disease risk factors by menopausal status:A population based study among Iranian women[J].hRYh htheroscler,2013,9 (6): 332- 336.
9Andrell P, Yu W, Gersbach P, et al. Long - term effects of spinal cord stim- ulation on angina symptoms and quality of life in patients with refractory angina pectoris - - results from the European Angina Registry Link Study (EARL) [J]. Heart,2010,96(14) : 1 132 - 1 136.
10Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA 2002 guideline update formanagement of patientswith unstable angina and non - ST - seg- ment elevation myocardial infarction summary article[J]. J Am CollCardiol, 2002,40(7) : 1 566 - 1 574.
